|

AKERO THERAPEUTICS INC (AKRO)

US00973Y1082 - Common Stock

16.74  +0.08 (+0.48%)

After market: 16.461 -0.28 (-1.67%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates.

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
EBITDA
YoY % growth
-80.13M-100.85M
-25.86%		-115.12M
-14.15%		-148.063M
-28.62%		N/AN/AN/A
EBIT
YoY % growth
-80.15M
-75.58%		-100.89M
-25.88%		-115.16M
-14.14%		-148.232M
-28.72%
Operating Margin
N/AN/AN/AN/A
EPS
YoY % growth
-2.48-2.89
-16.53%		-2.92
-1.04%		-2.79
4.44%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.79
-61.59%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		-43.86MN/AN/AN/AN/A
EBIT
Q2Q % growth		-44.365M
-74.53%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSuprise
Q3 2023
Q2Q % growth		 -0.71
22.83%		-0.69-0.02-2.18%
Q2 2023
Q2Q % growth		 -0.60
22.08%		-0.640.046.33%
Q1 2023
Q2Q % growth		 -0.55
25.68%		-0.690.1419.76%
Q4 2022
Q2Q % growth		 -0.49
47.31%		-0.810.3239.80%
Q3 2022
Q2Q % growth		 -0.92
-31.43%		-0.75-0.17-22.22%
Q2 2022
Q2Q % growth		 -0.77
7.23%		-0.870.1011.81%
Q1 2022
Q2Q % growth		 -0.74
-72.09%		-0.810.079.09%
Q4 2021
Q2Q % growth		 -0.93
-8.14%		-0.83-0.10-11.42%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSuprise
Q3 2023
Q2Q % growth		 %
Q2 2023
Q2Q % growth		 %
Q1 2023
Q2Q % growth		 %
Q4 2022
Q2Q % growth		 %
Q3 2022
Q2Q % growth		 %
Q2 2022
Q2Q % growth		 %
Q1 2022
Q2Q % growth		 %
Q4 2021
Q2Q % growth		 %
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -2.14% 0% 1.5%
RevenueN/A N/A N/A N/A